Pfizer Files Q1 2024 10-Q Report
Ticker: PFE · Form: 10-Q · Filed: 2024-05-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Pfizer's Q1 2024 10-Q is in: financials updated, check balance sheet details.
AI Summary
Pfizer Inc. filed its 10-Q for the period ending March 31, 2024, reporting on its financial performance. The filing details various financial statements and disclosures related to its operations, including information on common stock, additional paid-in capital, and retained earnings as of December 31, 2023, and March 31, 2024.
Why It Matters
This filing provides investors and analysts with a detailed look into Pfizer's financial health and operational performance for the first quarter of 2024, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate or unusual risk indicators.
Key Numbers
- 2024-03-31 — Reporting Period End Date (Marks the end of the financial quarter being reported.)
- 2024-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2023-12-31 — Previous Year-End Date (Provides a comparison point for financial figures from the end of the prior fiscal year.)
Key Players & Entities
- Pfizer Inc. (company) — Filer of the 10-Q report
- 20240331 (date) — End of the reporting period
- 20240508 (date) — Filing date
- 0000078003 (company) — Central Index Key for Pfizer Inc.
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides Pfizer Inc.'s quarterly financial statements and disclosures for the period ending March 31, 2024.
What is the reporting period covered by this document?
The reporting period covered is from January 1, 2024, to March 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2024.
What are some of the financial components detailed in the filing as of December 31, 2023?
The filing details components such as common stock, additional paid-in capital, treasury stock, retained earnings, and accumulated other comprehensive income as of December 31, 2023.
What is Pfizer Inc.'s Standard Industrial Classification (SIC) code?
Pfizer Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
0000078003-24-000107.txt : 20240508 0000078003-24-000107.hdr.sgml : 20240508 20240508155617 ACCESSION NUMBER: 0000078003-24-000107 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 24925659 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 10-Q 1 pfe-20240331.htm 10-Q pfe-20240331 0000078003 12/31 2024 Q1 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares pfe:operatingSegment xbrli:pure pfe:patent pfe:manufacturer pfe:treatmentCourse 0000078003 2024-01-01 2024-03-31 0000078003 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000078003 pfe:NotesDue20271.000Member 2024-01-01 2024-03-31 0000078003 2024-05-03 0000078003 us-gaap:ProductMember 2024-01-01 2024-03-31 0000078003 us-gaap:ProductMember 2023-01-01 2023-04-02 0000078003 2023-01-01 2023-04-02 0000078003 us-gaap:RoyaltyMember 2024-01-01 2024-03-31 0000078003 us-gaap:RoyaltyMember 2023-01-01 2023-04-02 0000078003 2024-03-31 0000078003 2023-12-31 0000078003 us-gaap:CommonStockMember 2023-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2023-12-31 0000078003 us-gaap:RetainedEarningsMember 2023-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000078003 us-gaap:ParentMember 2023-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2023-12-31 0000078003 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000078003 us-gaap:ParentMember 2024-01-01 2024-03-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000078003 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000078003 us-gaap:CommonStockMember 2024-03-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-03-31 0000078003 us-gaap:RetainedEarningsMember 2024-03-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000078003 us-gaap:ParentMember 2024-03-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-03-31 0000078003 us-gaap:CommonStockMember 2022-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2022-12-31 0000078003 us-gaap:RetainedEarningsMember 2022-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000078003 us-gaap:ParentMember 2022-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2022-12-31 0000078003 2022-12-31 0000078003 us-gaap:RetainedEarningsMember 2023-01-01 2023-04-02 0000078003 us-gaap:ParentMember 2023-01-01 2023-04-02 0000078003 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-04-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-02 0000078003 us-gaap:CommonStockMember 2023-01-01 2023-04-02 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-02 0000078003 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-04-02 0000078003 us-gaap:CommonStockMember 2023-04-02 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 0000078003 us-gaap:TreasuryStockCommonMember 2023-04-02 0000078003 us-gaap:RetainedEarningsMember 2023-04-02 0000078003 us-gaap:Accumulate